What are the effects of the COVID-19 pandemic and SARS-CoV-2 infection on mental health? NaturePortfolio amsterdamumc COVID19 SARSCoV2 Pandemic MentalHealth
By Neha MathurOct 5 2022Reviewed by Aimee Molineux In a recent study published in Nature Medicine, researchers reviewed the direct and indirect effects of coronavirus disease 2019 and the COVID-19-induced pandemic on mental health.
Study findings The majority of the general population demonstrated remarkable resilience and adaptation, as the researchers observed a slight increase in mental health symptom levels in the overall population. However, they found alternative explanations for the same; for instance, community support activities might have mitigated the mental health burden. Drug overdose or homicide likely masked the incidence of mental disorders.
Related StoriesEven before the COVID-19 pandemic, most countries had disorganized and understaffed mental health systems. To add to their plight, in the first 18 months of the pandemic, doctors abridged or postponed appointments and acute inpatient hospitalizations. A study analyzed electronic health records of the TriNetX network in the US, with 236,379 COVID-19 survivors and found that risks of incident neurological diagnoses were correlated with disease severity and increased by 78% and 32% when compared to influenza and other respiratory tract infections, respectively. Yet, whether post-acute sequelae of SARS-COV-2 infection form a unique pattern remains debatable.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Multiomic comparison shows a reduction in circulating monocytes correlated with persistent post-COVID-19 pulmonary fibrosisIn a new study, researchers identified distinguishing immune features of coronavirus disease 2019 (COVID-19) in patients with late-resolving pulmonary fibrosis (LR COVID-PF) and early-resolving (ER COVID-PF).
Read more »
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyObjective To estimate the effectiveness of mRNA vaccines against moderate and severe covid-19 in adults by time since second, third, or fourth doses, and by age and immunocompromised status. Design Test negative case-control study. Setting Hospitals, emergency departments, and urgent care clinics in 10 US states, 17 January 2021 to 12 July 2022. Participants 893 461 adults (≥18 years) admitted to one of 261 hospitals or to one of 272 emergency department or 119 urgent care centers for covid-like illness tested for SARS-CoV-2. Main outcome measures The main outcome was waning of vaccine effectiveness with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine during the omicron and delta periods, and the period before delta was dominant using logistic regression conditioned on calendar week and geographic area while adjusting for age, race, ethnicity, local virus circulation, immunocompromised status, and likelihood of being vaccinated. Results 45 903 people admitted to hospital with covid-19 (cases) were compared with 213 103 people with covid-like illness who tested negative for SARS-CoV-2 (controls), and 103 287 people admitted to emergency department or urgent care with covid-19 (cases) were compared with 531 168 people with covid-like illness who tested negative for SARS-CoV-2. In the omicron period, vaccine effectiveness against covid-19 requiring admission to hospital was 89% (95% confidence interval 88% to 90%) within two months after dose 3 but waned to 66% (63% to 68%) by four to five months. Vaccine effectiveness of three doses against emergency department or urgent care visits was 83% (82% to 84%) initially but waned to 46% (44% to 49%) by four to five months. Waning was evident in all subgroups, including young adults and individuals who were not immunocompromised; although waning was morein people who were immunocompromised. Vaccine effectiveness increased among most groups after a fourth dose in whom this booster was recommended. Conclusions Effecti
Read more »
Nursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomesNursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomes Nursing Omicron Coronavirus Disease COVID medrxivpreprint PublicHealthON UofT McMasterU UHN medrxivpreprint
Read more »
New study reveals possible brain mechanisms behind COVID-19 deliriumResearchers from King's College London have shown that when brain cells are directly exposed to blood taken from COVID-19 patients with delirium, there is an increase in cell death and a decrease in the generation of new brain cells. Delirium represents a state of confusion indicating that, in these patients, the COVID-19 infection had impacted the brain.
Read more »
Covid hospital admissions rise 50 per cent in a week fuelling 'new wave' fearsThe number of patients in hospital with covid has risen sharply for the first time since the peak of the last wave
Read more »